If a fibrinolytic drug is used for treatment of this woman's acute myocardial infarction, the adverse drug effect that is most likely to occur is (LQ)
|A||Acute renal failure|
|B||Development of anti platelet antibodies|
|C||Encephalitis secondary to liver dysfunction|
a. The most common serious adverse effect of the fibrolytics is bleeding, especially in the cerebral circulation.
b. The fibrinolytics do not usually have serious effects on the renal, hepatic, or hematologic systems. Unlike heparin, they do not induce antiplatelet antibodies.